{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 3
    }
  },
  "results": [
    {
      "discontinued_date": "09/11/2025",
      "update_type": "New",
      "initial_posting_date": "09/11/2025",
      "package_ndc": "0409-0181-25",
      "generic_name": "Gemcitabine Hydrochloride Injection",
      "contact_info": "844-646-4398",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "NDA200795"
        ],
        "brand_name": [
          "GEMCITABINE"
        ],
        "generic_name": [
          "GEMCITABINE"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-0181",
          "0409-0183",
          "0409-0182"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "GEMCITABINE HYDROCHLORIDE"
        ],
        "rxcui": [
          "1720960",
          "1720975",
          "1720977"
        ],
        "spl_id": [
          "3a284abb-8c57-47dc-a138-5a6e6ab92b05",
          "c0f06508-36d7-4325-a425-707d254d185b"
        ],
        "spl_set_id": [
          "dc02a23b-3ff9-4441-aa91-8e9e629a7315",
          "e18ed1cb-7dd0-4001-bfda-17d1f4587fb8"
        ],
        "package_ndc": [
          "0409-0181-01",
          "0409-0183-01",
          "0409-0182-01",
          "0409-0181-25",
          "0409-0182-25",
          "0409-0183-25"
        ],
        "unii": [
          "U347PV74IL"
        ]
      },
      "update_date": "09/11/2025",
      "therapeutic_category": [
        "Oncology"
      ],
      "dosage_form": "Injection",
      "presentation": "Gemcitabine Hydrochloride, Injection, 1 g/26.3 mL (38 mg/mL), sterile solution in a single-dose glass vial  NovaPlus (NDC 0409-0181-25)",
      "company_name": "Hospira, Inc., a Pfizer Company",
      "status": "To Be Discontinued"
    }
  ]
}